email

Email:

info@biotech-pack.com

Free Quote
百泰派克蛋白质测序
百泰派克蛋白质组学服务
百泰派克生物制药分析服务
百泰派克代谢组学服务

Principles and Applications of iTRAQ Proteomics

In multi-sample comparison, disease mechanism analysis, and drug target screening, iTRAQ proteomics is increasingly favored by researchers for its advantages of high throughput, high sensitivity, and high consistency.

 

I. Detailed explanation of iTRAQ proteomics principle: How is multi-sample protein quantification achieved?

iTRAQ is based onmass spectrometry-based relative and absolute quantification methods, utilizing isotopic tags to label peptides from different samples with equal mass. At the MS/MS level, different mass 'reporter ions' are released, and quantification is achieved based on their intensity. 

1. iTRAQ labeling structure:

Each iTRAQ reagent consists of three parts:

(1) Reporter group: 114–121 Da, marking different samples

(2)Balance group: adjusts the overall molecular weight consistency

(3)Peptide reactive group: reacts with peptide N-terminus and lysine side chains. The equal mass design of various tags ensures that all labeled peptides have identical mass in the primary mass spectrometry, and are distinguished by reporter ion mass in the secondary mass spectrometry.

 

2. iTRAQ proteomicsexperimental workflow:

(1) Protein extraction → Trypsin digestion;

(2) Each sample is labeled with different iTRAQ tags (e.g., 114, 115, 116...);

(3) All labeled peptides are mixed, followed by liquid chromatography separation + high-resolution LC-MS/MS analysis;

(4) Reporter ions are released during MS/MS fragmentation, and quantification is based on their intensity;

(5) Data analysis includes peptide identification, protein annotation, differential analysis, etc.

 

II. Applications of iTRAQ proteomics

1. Disease mechanism research

By comparing protein expression profiles in healthy and diseased states, differential expression proteins can be screened to provide a basis for disease biomarker discovery and pathway mechanism research.

 

2. Drug mechanism analysis

By comparing protein expression changes between drug-treated and control groups, drug targets and downstream signaling pathways can be explored, providing support for new drug development.

 

3. Developmental and temporal research

iTRAQ can be used to label samples at different time points, enabling dynamic monitoring of protein expression changes, suitable for research scenarios such as embryo development and cell differentiation.

 

4. Cross-omics joint analysis

iTRAQ is often used in conjunction with metabolomics, transcriptomics, and other technologies to construct multi-dimensional omics association networks, revealing key regulatory modules in complex biological processes. Biotech companies like Biotech Park support joint analysis of iTRAQ with phosphorylation modifications, metabolomics, immunomics, etc., assisting in the construction of systems biology models.

 

III. Limitations and solutions of iTRAQ technology

 

Limitations Explanation Solutions
Ratio compression Reporter ions are subject to co-fragmentation interference, leading to quantitative bias Use MS3-level mass spectrometry, narrow window selection strategies
High labeling cost Reagent prices and equipment requirements are high Precisely plan sample grouping to enhance data value
Strong dependence on mass spectrometry Requires high-resolution platforms Collaborate with professional platforms

  

As a mature multi-channel quantitative proteomics technology, iTRAQ continues to play a key role in life sciences, drug research, translational medicine, and other fields. Itshigh throughput, multi-sample parallel quantificationcapability is especially suitable for exploring differential proteins, constructing regulatory networks, validating biomarkers, and other complex topics.

 

Biotech Park provides one-stop iTRAQ proteomics services from sample preparation → iTRAQ labeling → high-resolution LC-MS/MS → data analysis and visualization reporting, and customizes optimal experimental strategies based on research objectives:

  • Multi-sample design and grouping recommendations
  • Report ion interference elimination optimization
  • In-depth bioinformatics analysis
  • Support for multi-omics joint analysis

Welcome to contact Biotech Park to efficiently advance your research projects!

 

 
Biotech Pioneers--Experts in Bioproduct Characterization and Multi-omics Mass Spectrometry Analysis Services

 

 
Related Services:

TMT/iTRAQ/MultiNotch Quantitative Proteomics Analysis

Submit Inquiry
Name *
Email Address *
Phone Number
Inquiry Project *
Project Description*

 

How to order?